The team of Alexander Titz at HIPS and collaborators developed novel pathoblockers acting on Lectins to fight infections with Pseudomonas aeruginosa. Read more on our website (English and German version available). https://www.helmholtz-hips.de/en/news-events/news/detail/news/sugar-based-inhibitors-disarm-the-pathogen-pseudomonas-aeruginosa/

@helmholtz_hips

Thanks for publicizing super work ... and long standing collaboration between Alexander Titz and our team in Grenoble for development of glycocompounds targeting Pseudmonoas lectins 😉

#glycotime